Skip to main content

Table 6 Changes in mean MAP and HR before the placement of laryngeal mask in each group

From: Minimal alveolar concentration of sevoflurane in combination with remimazolam in adults during laryngeal mask insertion: an up-down sequential allocation study

 

MAP (mmHg)

HR (bpm)

Group

Before placement

After placement

Z

P value

Before placement

After placement

Z

P value

RF0

78.1 ± 6.5

85.5 ± 6.8*

2.50

< 0.01

72.9 ± 9.8

87.2 ± 10.5*

4.11

< 0.01

RM0

78.2 ± 4.9

86.5 ± 6.0*

3.74

< 0.01

71.9 ± 5.7

86.1 ± 9.1*

4.12

< 0.01

RF1

78.1 ± 7.1

84.6 ± 8.2*

4.02

< 0.01

74.8 ± 10.0

83.6 ± 11.4*

3.77

< 0.01

RM1

79.2 ± 5.3

87.4 ± 6.2*

3.71

< 0.01

72.9 ± 5.8

85.2 ± 7.9*

4.42

< 0.01

RF2

78.9 ± 6.9

88.1 ± 7.5*

3.62

< 0.01

73.3 ± 7.9

82.7 ± 10.9*

3.82

< 0.01

RM2

79.6 ± 4.4

86.1 ± 5.3*

3.9

< 0.01

72.4 ± 6.8

81.2 ± 8.4*

3.46

< 0.01

RF3

76.6 ± 7.1

85.5 ± 7.9*

3.73

< 0.01

73.0 ± 10.0

83.7 ± 15.4*

3.23

< 0.01

RM3

78.4 ± 5.3

85.2 ± 6.0*

3.3

< 0.01

72.2 ± 6.2

83.9 ± 7.7*

4.16

< 0.01

  1. Data are presented as the mean standard deviation (SD)
  2. HR, heart rate; MAP, mean arterial pressure
  3. *P < 0.05 vs. before CLMA placement